spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

13th Annual Biomarkers Congress

Oxford Global - 13th Annual Biomarkers UK Congress

15-16 February 2018
Manchester Central Convention Complex, Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018, Manchester.

The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.

Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.

Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.

View the Agenda here:

http://bit.ly/2v4APod

Free Pre-Congress Live Webinars

Analytical Validation of Assays for the Qualification of Biomarkers
Thursday 19th October 2017 | 10am GMT
Hosted by John Allinson, ‎Head of Biomarker Strategy at Drug Development Services, LGC & Darren Hodgson, Senior Principal Translational Scientist, Oncology iMED, AstraZeneca

Register today for free:

http://bit.ly/2xTtg29

Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.

Register today for free:

http://bit.ly/2xT7TR9

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

phone +44 (0)1865 248455
email info@oxfordglobal.co.uk
web https://www.biomarkers-congress.com/
email Oxford Global Ltd, Part 1st Floor, Godstow Court, Minns Business Park, Botley, Oxford, OX2 0JB
 
Print this page
Send to a friend
   
spacer
Industry Events

Drug Delivery Partnerships 2018

22-24 January 2018, PGA National Resort & Spa, Palm Beach Gardens, Florida

For 22 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of 3D_Cell_Culture_events_97 on Samedan

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>


News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement